Quantitative assessment of tumor blood flow in mice after treatment with different doses of an antiangiogenic agent with contrast-enhanced destruction-replenishment US

Radiology

Volumn 259, Issue 2, 2011, Pages 406-413

  Zhou, Jian Hua ^a   Cao, Long Hui ^b   Liu, Ji Bin ^d   Zheng, Wei ^a   Liu, Min ^a   Luo, Rong Zhen ^c   Han, Feng ^a   Li, An Hua ^a  

^a Departments of Ultrasound   (China)

^b Departments of Anesthesiology   (China)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYMETHYLCELLULOSE; SONOVUE; THALIDOMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOSE RESPONSE; ECHOGRAPHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; MICROVASCULATURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BLOOD FLOW;

ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANIMALS; CARBOXYMETHYLCELLULOSE SODIUM; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CONTRAST MEDIA; LIVER NEOPLASMS, EXPERIMENTAL; MICE; NEOVASCULARIZATION, PATHOLOGIC; RANDOM ALLOCATION; STATISTICS, NONPARAMETRIC; SULFUR HEXAFLUORIDE; THALIDOMIDE;

EID: 79955049240     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10101339     Document Type: Article

References (43)

1. Folkman J Tumor angiogenesis: Therapeutic implications N Engl J Med 1971 ; 285 ( 21 ): 1182-1186
2. Hlatky L , Hahnfeldt P , Folkman J Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us J Natl Cancer Inst 2002 ; 94 ( 12 ): 883-893 (Pubitemid 34778087)
3. Padhani AR , Neeman M Challenges for imaging angiogenesis Br J Radiol 2001 ; 74 ( 886 ): 886-890 (Pubitemid 33064630)
4. Lassau M , Chebil M , Chami L , Roche A A new functional imaging technique for the early functional evaluation of antiangiogenic treatment: Dynamic contrast-enhanced ultrasonography (DCE-US) Target Oncol 2008 ; 3 ( 2 ): 111-117
5. Miller JC , Pien HH , Sahani D , Sorensen AG , Thrall JH Imaging angiogenesis: Applications and potential for drug development J Natl Cancer Inst 2005 ; 97 ( 3 ): 172-187 (Pubitemid 40277367)
6. Padhani AR MRI for assessing antivascular cancer treatments Br J Radiol 2003 ; 76 ( spec no 1 ): S60-S80 (Pubitemid 39530317)
7. Zhu AX , Holalkere NS , Muzikansky A , Horgan K , Sahani DV Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma Oncologist 2008 ; 13 ( 2 ): 120-125 (Pubitemid 351342575)
8. Laking GR , Price PM Positron emission tomographic imaging of angiogenesis and vascu lar function Br J Radiol 2003 ; 76 ( spec no 1 ): S50-S59 (Pubitemid 39530316)
9. Wei K , Jayaweera AR , Firoozan S , Linka A , Skyba DM , Kaul S Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion Circulation 1998 ; 97 ( 5 ): 473-483 (Pubitemid 28090220)
10. Lucidarme O , Franchi-Abella S , Correas JM , Bridal SL , Kurtisovski E , Berger G Blood flow quantification with contrast-enhanced US: "entrance in the section" phenomenon- phantom and rabbit study Radiology 2003 ; 228 ( 2 ): 473-479 (Pubitemid 36910090)
11. Wei K , Le E , Bin JP , Coggins M , Thorpe J , Kaul S Quantification of renal blood flow with contrast-enhanced ultrasound J Am Coll Cardiol 2001 ; 37 ( 4 ): 1135-1140 (Pubitemid 32217618)
12. Rim SJ , Leong-Poi H , Lindner JR , et al Quantification of cerebral perfusion with "real-time" contrast-enhanced ultrasound Circulation 2001 ; 104 ( 21 ): 2582-2587 (Pubitemid 33104797)
13. Malm S , Frigstad S , Helland F , Oye K , Slordahl S , Skjarpe T Quantification of resting myocardial blood flow velocity in normal humans using real-time contrast echocardiography: A feasibility study Cardiovasc Ultrasound 2005 ; 3 : 16-24
14. Cosgrove D , Eckersley R , Blomley M , Harvey C Quantification of blood flow Eur Radiol 2001 ; 11 ( 8 ): 1338-1344 (Pubitemid 32755616)
15. Krix M , Kiessling F , Vosseler S , et al Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography Cancer Res 2003 ; 63 ( 23 ): 8264-8270 (Pubitemid 37549477)
16. Bertolotto M , Pozzato G , Crocé LS , et al Blood flow changes in hepatocellular carcinoma after the administration of thalidomide assessed by reperfusion kinetics during microbubble infusion: Preliminary results Invest Radiol 2006 ; 41 ( 1 ): 15-21 (Pubitemid 44378274)
17. Des Guetz G , Uzzan B , Nicolas P , et al Microvessel density and VEGF expression are prognostic factors in colorectal cancer: Meta-analysis of the literature Br J Cancer 2006 ; 94 ( 12 ): 1823-1832 (Pubitemid 43882572)
18. Phoophitphong T , Hanprasertpong J , Dechsukhum C , Geater A Correlation of angiogenesis and recurrence-free survival of early stage cervical cancer patients undergoing radical hysterectomy with pelvic lymph node dissection J Obstet Gynaecol Res 2007 ; 33 ( 6 ): 840-848 (Pubitemid 350086518)
19. Xie XD , Qu SX , Liu ZZ , Zhang F , Zheng ZD Study on relationship between angiogenesis and micrometastases of peripheral blood in breast cancer J Cancer Res Clin Oncol 2009 ; 135 ( 3 ): 413-419
20. Medinger M , Esser N , Zirrgiebel U , Ryan A , Jürgensmeier JM , Drevs J Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma Anticancer Res 2009 ; 29 ( 12 ): 5065-5076
21. Zhang N , Wang L , Liang Y , et al The antiangiogenic effects of tyroservatide on animal models of hepatocellular carcinoma J Cancer Res Clin Oncol 2009 ; 135 ( 10 ): 1447-1453
22. Tozer GM Measuring tumour vascular response to antivascular and antiangiogenic drugs Br J Radiol 2003 ; 76 ( spec no 1 ): S23-S35 (Pubitemid 39530313)
23. D'Amato RJ , Loughnan MS , Flynn E , Folkman J Thalidomide is an inhibitor of angiogenesis Proc Natl Acad Sci U S A 1994 ; 91 ( 9 ): 4082-4085 (Pubitemid 24139577)
24. Kenyon BM , Browne F , D'Amato RJ Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization Exp Eye Res 1997 ; 64 ( 6 ): 971-978 (Pubitemid 27314772)
25. Teo SK Properties of thalidomide and its analogues: Implications for anticancer therapy AAPS J 2005 ; 7 ( 1 ): E14-E19 (Pubitemid 41554303)
26. Guide for the Care and Use of Laboratory Animals Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council. Washington, DC: National Academy Press, 1996.
27. Zhu BD , Yuan SJ , Zhao QC , Li X , Li Y , Lu QY Antitumor effect of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma World J Gastroenterol 2005 ; 11 ( 9 ): 1382-1386 (Pubitemid 40425926)
28. Zhou JH , Cao LH , Zheng W , Liu M , Han F , Li AH Contrast-enhanced gray-scale ultrasound for quantitative evaluation of tumor response to chemotherapy: Preliminary results with a mouse hepatoma model AJR Am J Roentgenol 2011 ; 196 ( 1 ): W13-W17
29. Kotoh T , Dhar DK , Masunaga R , et al Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice Surgery 1999 ; 125 ( 5 ): 536-544 (Pubitemid 29226926)
30. Belo AV , Barcelos LS , Teixeira MM , Ferreira MA , Andrade SP Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice Cancer Invest 2004 ; 22 ( 5 ): 723-729 (Pubitemid 40064733)
31. Weidner N , Semple JP , Welch WR , Folkman J Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma N Engl J Med 1991 ; 324 ( 1 ): 1-8
32. Jubb AM , Oates AJ , Holden S , Koeppen H Predicting benefit from anti-angiogenic agents in malignancy Nat Rev Cancer 2006 ; 6 ( 8 ): 626-635 (Pubitemid 44140860)
33. Kabbinavar F , Hurwitz HI , Fehrenbacher L , et al Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 2003 ; 21 ( 1 ): 60-65
34. Miles KA Tumour angiogenesis and its relation to contrast enhancement on computed tomography: A review Eur J Radiol 1999 ; 30 ( 3 ): 198-205 (Pubitemid 29343737)
35. Davis DW , McConkey DJ , Abbruzzese JL , Herbst RS Surrogate markers in antiangiogenesis clinical trials Br J Cancer 2003 ; 89 ( 1 ): 8-14 (Pubitemid 36897928)
36. Mabuchi S , Kawase C , Altomare DA , et al Vascular endothelial growth factor is a promising therapeutic target for the treatment of clear cell carcinoma of the ovary Mol Cancer Ther 2010 ; 9 ( 8 ): 2411-2422
37. Hasan J , Byers R , Jayson GC Intra-tumoural microvessel density in human solid tumours Br J Cancer 2002 ; 86 ( 10 ): 1566-1577 (Pubitemid 34628110)
38. De Giorgi U , Aliberti C , Benea G , Conti M , Marangolo M Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors Clin Cancer Res 2005 ; 11 ( 17 ): 6171-6176 (Pubitemid 41262944)
39. Lassau N , Lamuraglia M , Chami L , et al Gastrointestinal stromal tumors treated with imatinib: Monitoring response with contrastenhanced sonography AJR Am J Roentgenol 2006 ; 187 ( 5 ): 1267-1273 (Pubitemid 44630831)
40. Zhou J , Zheng W , Cao L , Liu M , Han F , Li A Antiangiogenic tumor treatment: Noninvasive monitoring with contrast pulse sequence imaging for contrast-enhanced grayscale ultrasound Acad Radiol 2010 ; 17 ( 5 ): 646-651
41. Guibal A , Taillade L , Mulé S , et al Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: Effect of discontinuing anti-VEGF therapy Radiology 2010 ; 254 ( 2 ): 420-429
42. Singhal S , Mehta J Thalidomide in cancer Biomed Pharmacother 2002 ; 56 ( 1 ): 4-12 (Pubitemid 34155405)
43. Martin L , Green B , Renshaw C , et al Examining the technique of angiogenesis assessment in invasive breast cancer Br J Cancer 1997 ; 76 ( 8 ): 1046-1054 (Pubitemid 27434662)